Article Details
Retrieved on: 2022-04-22 15:45:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Catalent has announced a multi-year $350m investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here